Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Intra-Cellular Therapies Inc ITCI

Healthcare Psychedelics
Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders. The Company leverages intracellular approach to develop treatments for people living with complex psychiatric and neurologic diseases. The Company’s product, CAPLYTA (lumateperone), is an oral, once daily atypical... see more

Recent & Breaking News (NDAQ:ITCI)

Intra-Cellular Therapies Provides Corporate Update and Reports Second Quarter 2019 Financial Results

GlobeNewswire August 7, 2019

Intra-Cellular Therapies to Present at the Canaccord Genuity 39th Annual Growth Conference

GlobeNewswire August 6, 2019

Intra-Cellular Therapies to Host Conference Call to Provide Regulatory Update Following Recent Meeting with FDA

GlobeNewswire August 5, 2019

Intra-Cellular Therapies Provides Update on FDA Advisory Committee Meeting for Lumateperone for the Treatment of Schizophrenia

GlobeNewswire July 23, 2019

Intra-Cellular Therapies Announces Positive Top-line Results from a Phase 3 Trial of Lumateperone in Patients with Bipolar Depression

GlobeNewswire July 8, 2019

Intra-Cellular Therapies Appoints Karen Patruno Sheehy, Esq. as Senior Vice President, Chief Compliance Officer

GlobeNewswire July 2, 2019

Intra-Cellular Therapies to Present at JMP Securities Life Sciences Conference

GlobeNewswire June 19, 2019

Intra-Cellular Therapies Announces FDA Advisory Committee Meeting to Review the NDA for Lumateperone for the Treatment of Schizophrenia in Adults

GlobeNewswire June 13, 2019

Intra-Cellular Therapies to Present at Jefferies 2019 Global Healthcare Conference

GlobeNewswire May 30, 2019

Intra-Cellular Therapies to Present at 2019 RBC Capital Markets Global Healthcare Conference

GlobeNewswire May 16, 2019

Intra-Cellular Therapies Announces Presentations on Lumateperone Schizophrenia Program at the American Psychiatric Association (APA) Annual Meeting

GlobeNewswire May 15, 2019

Intra-Cellular Therapies Reports First Quarter 2019 Financial Results and Provides Corporate Update

GlobeNewswire May 8, 2019

Intra-Cellular Therapies to Host First Quarter 2019 Financial Results Conference Call and Webcast

GlobeNewswire May 2, 2019

Intra-Cellular Therapies Presents Additional Results From Long-term Open Label Safety Study of Lumateperone at the 2019 Congress of the Schizophrenia International Research Society

GlobeNewswire April 15, 2019

Intra-Cellular Therapies Announces Presentation of Lumateperone Long-term Open Label Safety Study at the 2019 Congress of the Schizophrenia International Research Society

GlobeNewswire April 9, 2019

Intra-Cellular Therapies Continues to Strengthen Its Commercial Leadership Team; John A. Bardi Appointed as Senior Vice President, Market Access, Policy and Government Affairs

GlobeNewswire March 26, 2019

Intra-Cellular Therapies to Present at The Cowen and Company 39th Annual Health Care Conference

GlobeNewswire March 5, 2019

Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2018 Financial Results and Provides Corporate Update

GlobeNewswire February 27, 2019

Intra-Cellular Therapies to Present at the 8th Annual SVB Leerink Global Healthcare Conference

GlobeNewswire February 21, 2019

Intra-Cellular Therapies to Present at the 37th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 3, 2019